[Therapy concept: herceptin in combination with arimidex].
作者信息
von Minckwitz G
出版信息
Onkologie. 2002 Dec;25 Suppl 5:22 ; discussion 22-4.
PMID:23573617
Abstract
摘要
相似文献
1
[Therapy concept: herceptin in combination with arimidex].
Onkologie. 2002 Dec;25 Suppl 5:22 ; discussion 22-4.
2
[Combination therapy herceptin+taxotere/Herceptin+navelbine].
Onkologie. 2002 Dec;25 Suppl 5:15-6.
3
[Combination therapy herceptin+xeloda].
Onkologie. 2002 Dec;25 Suppl 5:17-8; discussion 19.
4
[Therapy concept: herceptin with anthracyclines].
Onkologie. 2002 Dec;25 Suppl 5:19-21; discussion 21.
5
How to treat hormone receptor-positive, human epidermal growth factor receptor 2-amplified breast cancer.
J Clin Oncol. 2009 Nov 20;27(33):5492-4. doi: 10.1200/JCO.2009.23.8089. Epub 2009 Sep 28.
6
[DCIS and HER2/neu].
Onkologie. 2002 Dec;25 Suppl 5:11-2; discussion 13.
7
The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers.
Breast Cancer Res Treat. 2007 Mar;102(1):43-9. doi: 10.1007/s10549-006-9307-8. Epub 2006 Aug 8.
8
Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.
J Clin Oncol. 2009 Nov 20;27(33):5538-46. doi: 10.1200/JCO.2009.23.3734. Epub 2009 Sep 28.
9
Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancer.
Breast. 2011 Feb;20(1):34-8. doi: 10.1016/j.breast.2010.06.005. Epub 2010 Jul 16.
10
[Herceptin monotherapy in HER2(+) recurrent breast carcinoma].
Onkologie. 2002 Dec;25 Suppl 5:14-5.
Zotero 插件